Nuzenio

Reports Interim Data

Reports Interim Data news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients - GlobeNewswireGlobeNewswire · Fri, 31 Jul 2026 12:10:00 GMTMGM China Reports 2026 Interim Financial Data - The Manila TimesThe Manila Times · Wed, 29 Jul 2026 22:58:22 GMTMGM China to Start Renovating About 100 Suites at MGM Macau - Stock TitanStock Titan · Wed, 29 Jul 2026 22:22:00 GMTProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 10:00:00 GMTPromis Reports No ARIA-E in PMN310 Alzheimer’s Trial Interim Data - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTProMIS Neurosciences (Nasdaq: PMN) reports positive six-month PMN310 Alzheimer’s trial data - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTBanco Comercial Português Reports Interim Data on Share Buy-Back Transactions - The Globe and MailThe Globe and Mail · Sun, 26 Jul 2026 07:14:00 GMT

Timeline

Fri, 31 Jul 2026 12:10:00 GMTMoleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients - GlobeNewswire
Wed, 29 Jul 2026 22:58:22 GMTMGM China Reports 2026 Interim Financial Data - The Manila Times
Wed, 29 Jul 2026 22:22:00 GMTMGM China to Start Renovating About 100 Suites at MGM Macau - Stock Titan
Tue, 28 Jul 2026 10:00:00 GMTProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial - GlobeNewswire
Tue, 28 Jul 2026 07:00:00 GMTPromis Reports No ARIA-E in PMN310 Alzheimer’s Trial Interim Data - Yahoo Finance
Tue, 28 Jul 2026 07:00:00 GMTProMIS Neurosciences (Nasdaq: PMN) reports positive six-month PMN310 Alzheimer’s trial data - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Reports Interim Data.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.